Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating nitrogen compound concentration (HP:0004364)help
Parent Node:
expand
Abnormal circulating creatinine concentration (HP:0012100)help
Parent Node:
expand
Azotemia (HP:0002157)help
..Starting node
..expand
Elevated circulating creatinine concentration (HP:0003259)help
Term ID: 3259
Name: Elevated circulating creatinine concentration
Synonym: Elevated creatinine; Elevated serum creatinine; High blood creatinine level; Increased creatinine; Increased serum creatinine
Definition: An increased amount of creatinine in the blood.
Comments:
Reference: HP:0003259
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandHyperammonemia (HP:0001987) help
..expandHyperuricemia (HP:0002149) help
..expandHypouricemia (HP:0003537) help
..expandIncreased blood urea nitrogen (HP:0003138) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003259HP:0003259Elevated circulating creatinine concentration0ADAMTS13 CL E G H110931366OMIM:274150Thrombotic thrombocytopenic purpura, hereditary.129
HP:0003259HP:0003259Elevated circulating creatinine concentration0ALG5 CL E G H2988020266ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent
HP:0003259HP:0003259Elevated circulating creatinine concentration0ALG8 CL E G H7905323161OMIM:608104Congenital disorder of glycosylation, type Ih46
HP:0003259HP:0003259Elevated circulating creatinine concentration0ALG9 CL E G H7979615672ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent93
HP:0003259HP:0003259Elevated circulating creatinine concentration0APRT CL E G H353626OMIM:614723Adenine phosphoribosyltransferase deficiency19
HP:0003259HP:0003259Elevated circulating creatinine concentration0BICC1 CL E G H8011419351ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent5
HP:0003259HP:0003259Elevated circulating creatinine concentration0C3 CL E G H7181318OMIM:612925Hemolytic uremic syndrome, atypical, susceptibility to, 5.92
HP:0003259HP:0003259Elevated circulating creatinine concentration0CC2D2A CL E G H5754529253OMIM:619111COACH SYNDROME 2; COACH2247
HP:0003259HP:0003259Elevated circulating creatinine concentration0CCND1 CL E G H5951582ORPHA:29073Multiple myelomaHP:0040282 - Frequent1
HP:0003259HP:0003259Elevated circulating creatinine concentration0CD46 CL E G H41796953OMIM:612922Hemolytic uremic syndrome, atypical, susceptibility to, 2.39
HP:0003259HP:0003259Elevated circulating creatinine concentration0CFB CL E G H6291037OMIM:612924Hemolytic uremic syndrome, atypical, susceptibility to, 4.30
HP:0003259HP:0003259Elevated circulating creatinine concentration0CFH CL E G H30754883OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.86
HP:0003259HP:0003259Elevated circulating creatinine concentration0CFHR1 CL E G H30784888OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0003259HP:0003259Elevated circulating creatinine concentration0CFHR3 CL E G H1087816980OMIM:235400Hemolytic uremic syndrome, atypical, susceptibility to, 1.
HP:0003259HP:0003259Elevated circulating creatinine concentration0CFI CL E G H34265394OMIM:612923Hemolytic uremic syndrome, atypical, susceptibility to, 3.57
HP:0003259HP:0003259Elevated circulating creatinine concentration0COQ7 CL E G H102292244OMIM:616733Coenzyme Q10 deficiency, primary, 81
HP:0003259HP:0003259Elevated circulating creatinine concentration0CORIN CL E G H1069919012ORPHA:275555PreeclampsiaHP:0040284 - Very rare5
HP:0003259HP:0003259Elevated circulating creatinine concentration0CPT2 CL E G H13762330OMIM:608836Carnitine palmitoyltransferase II deficiency, lethal neonatal101
HP:0003259HP:0003259Elevated circulating creatinine concentration0CTNS CL E G H14972518ORPHA:411634Juvenile nephropathic cystinosisHP:0040283 - Occasional178
HP:0003259HP:0003259Elevated circulating creatinine concentration0DBH CL E G H16212689ORPHA:230Dopamine beta-hydroxylase deficiencyHP:0040282 - Frequent80
HP:0003259HP:0003259Elevated circulating creatinine concentration0DNAJB11 CL E G H5172614889ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent
HP:0003259HP:0003259Elevated circulating creatinine concentration0ELP1 CL E G H85185959OMIM:223900Neuropathy, hereditary sensory and autonomic, type III.133
HP:0003259HP:0003259Elevated circulating creatinine concentration0FAN1 CL E G H2290929170OMIM:614817Interstitial nephritis, karyomegalic.15
HP:0003259HP:0003259Elevated circulating creatinine concentration0FLT1 CL E G H23213763ORPHA:275555PreeclampsiaHP:0040284 - Very rare11
HP:0003259HP:0003259Elevated circulating creatinine concentration0GANAB CL E G H231934138ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent6
HP:0003259HP:0003259Elevated circulating creatinine concentration0HBB CL E G H30434827ORPHA:232Sickle cell anemiaHP:0040283 - Occasional580
HP:0003259HP:0003259Elevated circulating creatinine concentration0HNF1B CL E G H692811630OMIM:137920Renal cysts and diabetes syndrome90
HP:0003259HP:0003259Elevated circulating creatinine concentration0HPRT1 CL E G H32515157ORPHA:79233Hypoxanthine guanine phosphoribosyltransferase partial deficiencyHP:0040283 - Occasional76
HP:0003259HP:0003259Elevated circulating creatinine concentration0IFT140 CL E G H974229077ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent148
HP:0003259HP:0003259Elevated circulating creatinine concentration0INVS CL E G H2713017870OMIM:602088Nephronophthisis 2.106
HP:0003259HP:0003259Elevated circulating creatinine concentration0MLIP CL E G H9052321355OMIM:620138
HP:0003259HP:0003259Elevated circulating creatinine concentration0MUC1 CL E G H45827508OMIM:174000Tubulointerstitial kidney disease, autosomal dominant, 2.1
HP:0003259HP:0003259Elevated circulating creatinine concentration0NPHP1 CL E G H48677905OMIM:266900Senior-Loken syndrome 185
HP:0003259HP:0003259Elevated circulating creatinine concentration0PAX2 CL E G H50768616OMIM:120330Papillorenal syndrome39
HP:0003259HP:0003259Elevated circulating creatinine concentration0PKD1 CL E G H53109008ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent342
HP:0003259HP:0003259Elevated circulating creatinine concentration0PKD2 CL E G H53119009ORPHA:730Autosomal dominant polycystic kidney diseaseHP:0040281 - Very frequent106
HP:0003259HP:0003259Elevated circulating creatinine concentration0PKD2 CL E G H53119009OMIM:613095Polycystic kidney disease 2.106
HP:0003259HP:0003259Elevated circulating creatinine concentration0SLC22A12 CL E G H11608517989OMIM:220150Hypouricemia, renal, 156
HP:0003259HP:0003259Elevated circulating creatinine concentration0SLC41A1 CL E G H25442819429OMIM:619468NEPHRONOPHTHISIS-LIKE NEPHROPATHY 2; NPHPL2
HP:0003259HP:0003259Elevated circulating creatinine concentration0SLC4A1 CL E G H652111027OMIM:179800Renal tubular acidosis, distal, autosomal dominant109
HP:0003259HP:0003259Elevated circulating creatinine concentration0STOX1 CL E G H21973623508ORPHA:275555PreeclampsiaHP:0040284 - Very rare2
HP:0003259HP:0003259Elevated circulating creatinine concentration0THBD CL E G H705611784OMIM:612926Hemolytic uremic syndrome, atypical, susceptibility to, 6.60
HP:0003259HP:0003259Elevated circulating creatinine concentration0TMEM260 CL E G H5491620185OMIM:617478Structural heart defects and renal anomalies syndrome2
HP:0003259HP:0003259Elevated circulating creatinine concentration0TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHP:0040282 - Frequent56
HP:0003259HP:0003259Elevated circulating creatinine concentration0TTC26 CL E G H7998921882OMIM:619534BILIARY, RENAL, NEUROLOGIC, AND SKELETAL SYNDROME; BRENS
HP:0003259HP:0003259Elevated circulating creatinine concentration0WDR19 CL E G H5772818340OMIM:614376Short-Rib thoracic dysplasia 5 with or without polydactyly.95


Genes (45) :ADAMTS13 ALG5 ALG8 ALG9 APRT BICC1 C3 CC2D2A CCND1 CD46 CFB CFH CFHR1 CFHR3 CFI COQ7 CORIN CPT2 CTNS DBH DNAJB11 ELP1 FAN1 FLT1 GANAB HBB HNF1B HPRT1 IFT140 INVS MLIP MUC1 NPHP1 PAX2 PKD1 PKD2 SLC22A12 SLC41A1 SLC4A1 STOX1 THBD TMEM260 TREX1 TTC26 WDR19

Diseases (35) :OMIM:274150 ORPHA:730 OMIM:608104 OMIM:614723 OMIM:612925 OMIM:619111 ORPHA:29073 OMIM:612922 OMIM:612924 OMIM:235400 OMIM:612923 OMIM:616733 ORPHA:275555 OMIM:608836 ORPHA:411634 ORPHA:230 OMIM:223900 OMIM:614817 ORPHA:232 OMIM:137920 ORPHA:79233 OMIM:602088 OMIM:620138 OMIM:174000 OMIM:266900 OMIM:120330 OMIM:613095 OMIM:220150 OMIM:619468 OMIM:179800 OMIM:612926 OMIM:617478 ORPHA:247691 OMIM:619534 OMIM:614376
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.